Select Committee on Science and Technology Written Evidence


APPENDIX 17

Memorandum from the Church of England Community and Public Affairs Unit

  1.  The terms of reference of the Church of England's Community and Public Affairs Unit require it to assist in the Church in making a constructive and informed response to issues facing contemporary society. The Unit reports to the Archbishops' Council and, through it, to the General Synod.

  2.  The Unit warmly welcomes the Science and Technology's decision to issue a Consultation Document on human reproduction and the law.

The balance between legislation, regulation and reproductive freedom; the role of Parliament in relation to reproductive technologies; the ethical framework for legislation

  3.  Reproductive matters fall within the law for the protection of people, including unborn people; for the avoidance of exploitation in an area of life where people are peculiarly vulnerable; and for the maintenance of public respect for the value and "given" quality of human life.

  4.  We are hesitant about some appeals to human rights sometimes heard in this debate. Children have a right to be brought up in circumstances which conduce to their well-being, but we are profoundly suspicious of the "right to have a child" when this involves more than normal corrective procedures. One reason for our view is that the belief that one has such a right may only intensify the pain of childlessness. We prefer to base our thinking on the privilege of having children and the danger of treating them as possessions.

  5.  There is however the right to seek treatment; and the right to be referred to a second doctor or clinic if the first does not wish to treat, for whatever reason.

  6.  The question has been raised about the need for a father, currently enshrined in the 1990 legislation. There is pressure from some ethical and legal commentators to have this clause removed, arguing that there is no reliable empirical evidence to support it, and that it discriminates against families without fathers. Whilst we recognise that families, however eccentric their form, may well be successful if they are loving, we would be very concerned to see this clause dropped. Such a step should not be taken without further serious debate and examination of its likely consequences.

  7.  Similarly there is some pressure to remove the need for both parties to consent to the use or destruction of frozen embryos. Laboratories or clinics which store frozen embryos need certainty when application is made to use or to destroy an embryo that they hold. Otherwise they might be in danger of being sued or losing their license. They should not have the responsibility of deciding what is to become of the embryos in their charge. This is a matter for the law and again, we resist the pressure to change it, and urge further serious debate which takes account of long-term social consequences, not just the immediate problems of individuals.

  8.  Legislation is appropriate where clear lines can be drawn, and where the moral and legal framework within which decisions are made can be precisely specified. The 14 day rule is an example; agreement on that made it possible to have a regulatory authority which could carefully examine specific applications in the areas of fertility treatment and research, including, now, embryonic stem cell research. Any alteration to this 14 day rule would be a breach of the trust on which the HFEA legislation was based. Such "lines in the sand" should only be changed after full public debate.

  9.  Regulation within legal guidelines makes good sense when the issues are technical and when a research field is undergoing rapid development, though the experts should remain morally accountable to the wider community. Matters such as abortion and surrogacy do not fit into this category because the issues surrounding them are by and large non-technical, public, and easy to understand, and therefore can benefit from public debate. The HFEA could presumably advise Parliament on, for example, the issue of viability outside the womb, but we think it important not to overload the HFEA with decisions which are marginal to its primary remit. A similar point can be made about the question of anonymity of gamete donors.

  10.  The situation in the UK compares favourably with that of the US, where only Federally funded research is ethically controlled whereas in the private sector (in most states) anything is permitted.

The context of other legislation in the UK, EU and internationally

  11.  There are advantages in trying to harmonise international legislation on these sorts of matters, if only to avoid tempting people to go abroad for illicit procedures. As Christians we believe that ethical principles are more than the concern of a particular society at a particular time. We believe we should, therefore, look to others as well as ourselves to develop appropriate protections. We recognise, however, that nothing for years to come is going to bring Germany into line with the rest of Europe. If this means that German women go abroad for treatment this is a matter for the Germans to address.

Challenges from new research and treatment and from changes in ethical and societal attitudes

  12.  We are interested to know where the measurement of change in society's attitudes to morality is taking place, and how such changes will be judged: are they an improvement or not?

  13.  Some principles ought to be inviolable, whatever the current ethical fashion. Among these are the respect for the life and integrity of persons, understood as an increasing imperative during pre-natal development, plus the safeguarding of this value and integrity by societal arrangements which forbid practices capable in the long or short term of undermining them. The medical profession, by its nature, has to concentrate on the immediate problems of individuals. It is therefore essential that the law is so framed as to take account of the wider social consequences of individual choices.

  14.  We would like reassurance that the Committee is asking key questions about human purpose and meaning. These are important to test the assumptions which may be underlying its approaches to human reproductive technologies and the role of the law.

The role of the HFEA

  15.  The HFEA has coped well with new issues which have arisen since 1990. New developments are arising all the time, which is an important reason for having a regulatory authority.

  16.  We believe that the HFEA should continue with a well-focused remit which corresponds to the scope of its expertise. It would be a mistake, in our view, for the Authority to widen its remit to include matters such as surrogacy, adoption and confidentiality, which arguably all fall within the area of child protection. They raise very different questions from those related to stem cells, CNR, sex selection and ante-natal diagnosis. These latter clearly fall within the scope of the Authority's expertise.

May 2004





 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 24 March 2005